Physician profile
Jaclyn Van Nes
NPI 1154592897
$1,367.50
in general payments reported to CMS, 2019-2025
20 companies · $80.75 in 2025
The $80.75 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $53.45 · 2021: $15.57 · 2022: $275 · 2023: $343 · 2024: $279 · 2025: $80.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $702.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.15 | 2020-2025 | Orilissa, Liletta, Lo Loestrin Fe |
| Pfizer INC. | $169.86 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $164.44 | 2023-2024 | Myfembree |
| Allergan, INC. | $121.87 | 2019-2020 | |
| Organon LLC | $94.08 | 2024-2025 | Nexplanon |
| Astellas Pharma Global Development | $63.85 | 2023-2024 | Veozah |
| C. R. Bard, INC. & Subsidiaries | $58.26 | 2024 | |
| Medtronic, INC. | $57.08 | 2022 | |
| Exeltis, USA INC. | $42.91 | 2023 | Slynd |
| Myovant Sciences INC. | $42.21 | 2022 | |
| Daiichi Sankyo INC. | $41.90 | 2019-2023 | Injectafer |
| Sage Therapeutics, LLC | $35.24 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $29.25 | 2019 | |
| Duchesnay USA Incorporated | $28.72 | 2019 | |
| Hologic Sales and Service, LLC | $21.71 | 2024 | Myosure Tissue Removal Device |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $20.33 | 2022 | |
| Exact Sciences Corporation | $16.84 | 2025 | Cologuard Collection Kit |
| Minerva Surgical, INC | $13.16 | 2019 | |
| Coopersurgical, INC. | $12.44 | 2022 | |
| Covidien LP | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Van Nes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.